OTC Healthcare in Georgia
Euromonitor International's OTC Healthcare in Georgia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 12 | Publication date: Feb 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Sales recover from 2004 crisis
Sales were dramatically eroded in 2004 by political unrest and economic concerns, with many consumers opting to purchase OTC healthcare on the black market or cutting back on overall consumption. However, growth was resumed in 2005 as consumers began to return to retail products, assisted by higher disposable income levels and improvements in distribution.
Medicated skin care most dynamic as retailers expand range
Chained chemists/pharmacies expanded dramatically in 2005, with this widening the range of OTC healthcare products available. Medicated skin care benefited strongly from this in 2005 and was the most dynamic within overall OTC healthcare as a result. Consumer awareness of such products grew dramatically, partly due to the presence of sales advisors in such outlets.
Heavy fragmentation with reliance on imported generics
There are high levels of fragmentation within OTC healthcare. There are no significant domestic players and sales are dominated by a large number of imported generics sold at low prices. The leading players are global leaders such as Nycomed, Aventis and Novartis, with these generally benefiting from more consistent distribution. However, in volume and value terms, these players are dwarfed by the combined sales of generics.
Distribution limited to chemists/pharmacies but growing in geographical presence
Chained chemists/pharmacies continued to expand across Georgia in 2005, offering greater rural access to OTC healthcare. Chains dominated sales by 2005 and boosted sales by offering a wider range of products, thus reducing the OTC product shortages that are still experienced in the country. This encouraged many consumers to trade up to retail OTC healthcare from black market equivalents.
Strong growth for forecast period
Strong growth is expected for OTC healthcare during the forecast period, provided that the economic and political condition of the country remains stable. The government has pledged to focus on improving the provision of healthcare in general, while chained chemists/pharmacies have aggressive expansion plans for the country. The strongest growth will be seen for basic OTC healthcare such as analgesics and cough, cold and allergy (hay fever) remedies, which will benefit from consumers trading up to retail products from the black market. Niches will in general continue to be under-developed and consumers will continue to seek out low-priced products due to low disposable incomes.
Table of contents
OTC HEALTHCARE IN GEORGIA : MARKET INSIGHT
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Life Expectancy
Table 1 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 2 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 3 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
3.3 Competitive Environment
Table 4 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 5 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profile: Borisov Medical Preparations Plant
Summary 1 Borisov Medical Preparations Plant: Operational Indicators 2005
3.5 Leading Company Profile: Krka dd
Summary 2 Krka dd: Operational Indicators 2005
3.6 New Product Developments
Summary 3 OTC Healthcare: New Product Launches 2004-2005
3.7 Retail Distribution
Table 6 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 7 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.8 Retailer Activity and Private Label Trends
3.9 Forecast Market Performance
Table 8 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. DEFINITIONS